Abstract:Methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading causes of increased amputation, morbidity and mortality among patients with diabetic foot infections. These infections are refractory to antibiotics. Therefore, alternative therapy using phages has re-emerged as a promising option to treat such infections. The present study was conducted to evaluate the efficacy of phage in treating diabetic wound infection caused by MRSA 43300 in rats. Phages were isolated against MRSA 43300 and purified as per standard procedures. Diabetes was induced in healthy albino rats using streptozotocin. The minimum lethal dose (MLD) of MRSA and minimum protective dose (MPD) of phage was identified. A full-size excision wound was created on the back of rats. The rats were divided into five groups (Group I – Non-infected and untreated, Group II- Infected and untreated, Group III - Infected and phage challenged, Group IV- Infected and antibiotic treated, Group V – Non-infected and phage treated). Groups II, III and IV were infected with MLD of MRSA 43300. After 48 h of infection, Group III was treated with a single dose of MPD of phage and group IV was treated with mupirocin on all days. The wound were sampled on designated days, Gram stain was done to detect for the presence of pus cells and Gram positive cocci. Standard culture methods were used to confirm the presence of phage and MRSA 43300 and estimate their titre on different days among different groups. Wound contraction rate was recorded to compare the duration of wound healing between all the groups. Group II served as bacterial control in which all the rats died after 72h. The phage treated group III showed the presence of Gram positive cocci and pus cells in Gram stain till 6 days. Viable MRSA was isolated till 4 days post treatment and more than 50% of the wound contracted by day 12 of infection. Phage-treated group showed better wound contraction rate and faster bacterial clearance compared to antibiotic-treated group. The results of the present study help to reconsider phage therapy for treatment of drug-resistant infection.

Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection

Reassessing the Forgotten Cure: Efficacy of Bacteriophage As a Therapeutic Agent Against MRSA in Diabetic Rats

Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant <i>Staphylococcus aureus</i>

Optimized Dosing and Delivery of Bacteriophage Therapy for Wound Infections

Bacteriophage‐cocktail hydrogel dressing to prevent multiple bacterial infections and heal diabetic ulcers in mice

The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review

Chitosan-Based Microparticle Encapsulated Acinetobacter baumannii Phage Cocktail in Hydrogel Matrix for the Management of Multidrug Resistant Chronic Wound Infection

Phages versus Antibiotics To Treat Infected Diabetic Wounds in a Mouse Model: a Microbiological and Microbiotic Evaluation

Development of phage-containing hydrogel for treating Enterococcus faecalis -infected wounds

Isolation, characterization, and antibacterial activity of lytic bacteriophage against methicillin-resistant Staphylococcus aureus causing bedsore and diabetic wounds

A Randomized, Placebo-controlled, Double-blind Clinical Trial of Bacteriophage Cocktails in Chronic Wound Infections

Bacteriophage therapy for Acinetobacter baumannii-induced superficial wounds in experimental mice.

Dual phage-incorporated electrospun polyvinyl alcohol-eudragit nanofiber matrix for rapid healing of diabetic wound infected by Pseudomonas aeruginosa and Staphylococcus aureus

Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant Staphylococcus aureus

Bacteriophage entrapment strategies for the treatment of chronic wound infections: a comprehensive review

Phage-liposome nanoconjugates for orthopedic biofilm eradication

Overcoming biological barriers to improve treatment of a Staphylococcus aureus wound infection

Phage therapy as a glimmer of hope in the fight against the recurrence or emergence of surgical site bacterial infections

Design of Phage-Cocktail–Containing Hydrogel for the Treatment of Pseudomonas aeruginosa–Infected Wounds

Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics

A Bacteriophage-Loaded Microparticle Laden Topical Gel for the Treatment of Multidrug-Resistant Biofilm-Mediated Burn Wound Infection